Health Care Select Sector SPDR (XLV)

Add to Watchlists
Create an Alert
74.39 +0.26  +0.35% NYSE Arca Jun 30, 8:00PM Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Description

Health Care Select Sector SPDR is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Health Care Select Sector TR USD index and has 15.01B USD assets under management. It has an forecasted dividend yield of 1.43%, a forecasted PE ratio of 22.69, and a forecasted price to book value of 3.960. The fund has a net expense ratio of 0.15%, turns over its positions 2.99% per year, and is traded on the New York Stock Exchange Arca.

XLV Key Info

Expense Ratio (1-31-15) 0.15%
Assets Under Management (6-29-15) 15.01B
30-Day Average Volume (6-30-15) 7.460M
Net Asset Value (6-29-15) 74.17
Discount or Premium to NAV (6-29-15) -0.06%
Turnover Ratio (9-30-14) 2.99%

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.03% 0.03% 0.00%
Stock 99.97% 99.97% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of June 29, 2015

XLV Region Exposure

Americas 95.60%
North America 95.60%
Latin America 0.00%
Greater Europe 4.40%
United Kingdom 0.00%
Europe Developed 4.40%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of June 26, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.26%
Industrials 0.00%
Real Estate 0.00%
Technology 0.74%
Utilities 0.00%
As of June 29, 2015

XLV Stock Market Capitalization

Giant 62.58%
Large 31.15%
Medium 6.24%
Small 0.00%
Micro 0.00%
As of June 29, 2015
View More Holdings

XLV Top 10 Holdings

Name % Weight Price % Chg
Johnson & Johnson 9.61% 97.46 -0.23%
Pfizer Inc 7.34% 33.53 -0.18%
Gilead Sciences Inc 6.02% 117.08 +1.41%
Merck & Co Inc 5.74% 56.93 -0.63%
Allergan PLC 4.40% 303.46 +1.41%
UnitedHealth Group Inc 4.13% 122.00 +0.67%
AbbVie Inc 4.10% 67.19 +0.01%
Amgen Inc 4.09% 153.52 +1.27%
Bristol-Myers Squibb Company 3.92% 66.54 +0.86%
Medtronic PLC 3.72% 74.10 +1.09%
As of June 29, 2015
Advertisement

XLV Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD 100.0%

XLV Manager Info

Name Tenure
John Tucker 15.17 yrs
Karl Schneider 0.16 yrs
Michael Feehily 4.17 yrs

XLV Risk Info

Beta 0.6878
Max Drawdown (All) 40.51%
Historical Sharpe (10y) 0.8354
Historical Sortino (All) 1.008
30-Day Rolling Volatility 12.49%
Daily Value at Risk (VaR) 1% (All) 3.12%
Monthly Value at Risk (VaR) 1% (All) 13.67%

XLV Fundamentals

Dividend Yield TTM (6-30-15) 1.29%
Weighted Average PE Ratio 23.83
Weighted Average Price to Sales Ratio 2.006
Weighted Average Price to Book Ratio 4.277
Weighted Median ROE 21.25%
Weighted Median ROA 9.36%
Forecasted Dividend Yield 1.43%
Forecasted PE Ratio 22.69
Forecasted Price to Sales Ratio 1.835
Forecasted Price to Book Ratio 3.960
Number of Holdings 56
As of June 29, 2015

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.48%
Forecasted Book Value Growth 7.86%
Forecasted Cash Flow Growth 9.52%
Forecasted Earnings Growth 12.25%
Forecasted Revenue Growth 10.30%
As of June 29, 2015

XLV Performance

  Returns Total Returns
1M -0.73% -0.39%
3M 0.83% 1.17%
6M 7.70% 8.38%
1Y 22.29% 23.95%
3Y 95.74% 105.4%
5Y 163.8% 188.4%
As of June 29, 2015

XLV Net Flows

1M 653.04M
3M 778.05M
6M 884.67M
YTD 1.407B
1Y 2.325B
3Y 4.249B
5Y 5.470B
As of May 31, 2015

XLV Attributes

Key Dates
Inception Date 12/16/1998
Last Annual Report Date 9/30/2014
Last Prospectus Date 1/31/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.